Background and Insight
More than 5 million people worldwide suffer from an advanced form of age-related macular degeneration (AMD) called geographic atrophy, where retinal cells die. Until now, there has been no treatment capable of restoring vision for these patients. The PRIMA system, approved in Europe in July and awaiting FDA clearance in the US, brings new hope to the healthcare field.
What Does This Mean for Your Daily Life?
If you or someone you know suffers from AMD, this technology could significantly improve quality of life. Better vision not only enhances personal well-being but also offers greater freedom and the ability to enjoy daily activities independently.
💡 How to Use This Knowledge
- Discuss with your doctor whether you might be a candidate for the PRIMA implant system.
- Stay updated on technological advances in health that could directly affect you.
- Share the information with family members who may be affected by AMD to open new doors for potential treatments.